OPKO Health Inc (NASDAQ:OPK)

3.69
Delayed Data
As of 4:00pm ET
 -0.16 / -4.16%
Today’s Change
3.61
Today|||52-Week Range
8.92
-24.69%
Year-to-Date
Weekly CEO Buys Highlight
Feb 19 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close3.85
Today’s open3.80
Day’s range3.68 - 3.84
Volume3,757,813
Average volume (3 months)4,516,270
Market cap$2.2B
Data as of 4:00pm ET, 02/20/2018

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)-422.48%
Earnings growth (next 5 years)+70.80%
Revenue growth (last year)+148.44%
P/E ratioNM
Price/Sales4.19
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...+0.53+1.11%
PBYIPuma Biotechnology I...0.000.00%
CLVSClovis Oncology Inc-0.44-0.81%
MNKMallinckrodt Plc-0.09-0.54%
Data as of 4:02pm ET, 02/20/2018

Financials

Next reporting dateFebruary 28, 2018
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$1.2B
Annual profit (last year)-$25.1M
Net profit margin-2.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer &
Senior Vice President
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts